ZYBT fundamentals
An in-depth look to Zhengye Biotechnology Holding Limited operating, investing, and financing activities
ZYBT free cash flow for H1 24 is 1.8 M USD. For 2023, ZYBT free cash flow was 5.79 M USD and operating cash flow was 6.83 M USD.
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
−6.00 M
−3.00 M
0.00
3.00 M
6.00 M
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
H1 '22
Jun 2022
H2 '22
Dec 2022
H1 '23
Jun 2023
H2 '23
Dec 2023
H1 '24
Jun 2024
TTM
Cash from operating activitiesYoY growth
1.29 M
—
1.19 M
—
1.15 M
−11.13%
5.54 M
+364.43%
2.04 M
+78.26%
7.58 M
Cash from investing activitiesYoY growth
−3.16 M
—
−757.21 K
—
−162.17 K
+94.86%
−1.46 M
−93.25%
−2.19 M
−1,252.81%
−3.66 M
Cash from financing activitiesYoY growth
4.88 M
—
−2.95 M
—
1.01 M
−79.38%
−3.66 M
−24.00%
−2.62 M
−360.53%
−6.28 M
Free cash flowYoY growth
−1.75 M
—
321.48 K
—
983.69 K
—
4.68 M
+1,356.34%
1.80 M
+82.87%
6.48 M